Skip to main content

Neuronetics, Inc 8-K, filed May 29, 2020

Neuronetics, Inc. (STIM)

8-K 2020-05-29 For: 2020-05-26
View Original
Added on April 10, 2026

About this 8-K

Neuronetics, Inc filed this 8-K on May 29, 2020, reporting on events of May 26, 2020.

Items reported

  • Item 5.07: Shareholder vote results

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENTREPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) May 26, 2020

NEURONETICS, INC.

(Exact name of registrant as specified in its charter)

Delaware 001-38546 33-1051425
(State or other jurisdiction<br><br><br>of incorporation) (Commission<br><br><br>File Number) (I.R.S. Employer<br><br><br>Identification No.)
3222 Phoenixville Pike, Malvern, PA 19355
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code (610)640-4202

(Former name or former address, if changed since last report.) Not applicable.

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading<br><br><br>Symbol (s) Name on each exchange<br><br><br>on which registered
Common Stock ($0.01 par value) STIM The Nasdaq Global Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17<br>CFR 240.14a-12)
--- ---
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
--- ---
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--- ---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 5.07. Submission of Matters to a Vote of Security Holders.

The Company held the Annual Meeting on May 26, 2020 (the “Annual Meeting”). A total of 16,030,450 shares of common stock, representing approximately 85.6% of the shares outstanding and eligible to vote and constituting a quorum, were represented in person or by valid proxies at the Annual Meeting. The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows:

Proposal 1: All of the nominees for director were elected to serve a one-year term until the 2021 Annual Meeting, or until their respective successors are elected and qualified, by the votes set forth in the table below:

Nominees For Withheld BrokerNon-Votes
John Bakewell 8,152,302 140,387 7,737,761
Cheryl Blanchard 6,034,897 2,257,792 7,737,761
Sheryl Conley 8,132,013 160,676 7,737,761
Brian Farley 7,047,323 1,245,366 7,737,761
Wilfred Jaeger 8,057,047 235,642 7,737,761
Glenn Muir 8,082,519 210,170 7,737,761

Proposal 2: The appointment of KPMG LLP as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2020 was ratified by the Company’s stockholders by the votes set forth in the table below:

For Against Abstained
15,947,015 78,072 5,363

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NONETICS, INC.
(Registrant)
Date: May 29, 2020 /s/ W. Andrew Macan
W. Andrew Macan
Senior Vice President, General Counsel, Chief Compliance Officer, Corporate Secretary and Member of the Office of the President (Co-Principal Executive Officer)

All values are in Euros.